Keystone Financial Planning Inc. Cuts Stock Position in Haleon PLC Sponsored ADR $HLN

Keystone Financial Planning Inc. lessened its holdings in Haleon PLC Sponsored ADR (NYSE:HLN) by 0.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 223,650 shares of the company’s stock after selling 1,269 shares during the period. Haleon comprises approximately 0.7% of Keystone Financial Planning Inc.’s holdings, making the stock its 26th biggest holding. Keystone Financial Planning Inc.’s holdings in Haleon were worth $2,319,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in HLN. Hanson & Doremus Investment Management raised its stake in shares of Haleon by 234.1% in the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after acquiring an additional 1,662 shares during the period. Bartlett & CO. Wealth Management LLC raised its stake in shares of Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after acquiring an additional 1,491 shares during the period. Banque Transatlantique SA purchased a new position in shares of Haleon in the 1st quarter valued at $27,000. Ransom Advisory Ltd purchased a new position in shares of Haleon in the 1st quarter valued at $31,000. Finally, Deutsche Bank AG raised its stake in shares of Haleon by 267.8% in the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after acquiring an additional 2,276 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.25 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The firm has a 50-day simple moving average of $9.38 and a 200 day simple moving average of $9.98. The company has a market cap of $41.17 billion, a PE ratio of 23.71, a P/E/G ratio of 2.74 and a beta of 0.20.

Haleon Increases Dividend

The company also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were given a $0.0555 dividend. This is a positive change from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date was Friday, August 15th. This represents a yield of 190.0%. Haleon’s payout ratio is currently 28.21%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HLN shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Barclays downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Finally, The Goldman Sachs Group raised shares of Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $12.33.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.